We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.49%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$58.1B
AUM Growth
+$5.28B
(+10%)
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
1.82%
Top 10 Holdings %
Top 10 Hldgs %
14.06%
Holding
4,799
New
857
Increased
1,497
Reduced
1,529
Closed
854
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$701M |
| 2 |
Pinduoduo
PDD
|
+$159M |
| 3 |
CrowdStrike
CRWD
|
+$152M |
| 4 |
UnitedHealth
UNH
|
+$143M |
| 5 |
SPDR Gold Trust
GLD
|
+$118M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.17B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$240M |
| 3 |
Microsoft
MSFT
|
+$184M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 5 |
Ulta Beauty
ULTA
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.49% |
| 2 | Consumer Discretionary | 6.34% |
| 3 | Healthcare | 4.58% |
| 4 | Financials | 4.54% |
| 5 | Industrials | 3.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
CALL
Compañía de Minas Buenaventura
BVN
$7.85B
| $457K | ﹤0.01% |
28,800
-95,400
| -77% | -$1.49M |
|
3102
inTEST
INTT
$173M
| $457K | ﹤0.01% |
34,516
-33,156
| -49% | -$392K |
|
3103
Fractyl Health
GUTS
$123M
| $457K | ﹤0.01% |
+61,708
| New | +$520K |
|
3104
CALL
Alaska Air
ALK
$5.15B
| $456K | ﹤0.01% |
+10,600
| New | +$396K |
|
3105
PUT
BRC Group Holdings
RILY
$277M
| $455K | ﹤0.01% |
21,500
-23,900
| -53% | -$480K |
|
3106
BlueLinx
BXC
$455M
| $455K | ﹤0.01% |
3,491
-11,660
| -77% | -$1.37M |
|
3107
Phibro Animal Health
PAHC
$1.38B
| $454K | ﹤0.01% |
35,135
-26,285
| -43% | -$315K |
|
|
GTHX
3108
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $454K | ﹤0.01% |
105,156
+88,938
| +548% | +$310K |
|
3109
Red Violet
RDVT
$859M
| $454K | ﹤0.01% |
+23,205
| New | +$425K |
|
3110
Edgewise Therapeutics
EWTX
$4.39B
| $453K | ﹤0.01% |
24,854
+13,244
| +114% | +$211K |
|
3111
VeriSign
VRSN
$25.3B
| $453K | ﹤0.01% |
2,390
-37,417
| -94% | -$7.35M |
|
3112
Amylyx Pharmaceuticals
AMLX
$2.05B
| $452K | ﹤0.01% |
159,309
+125,859
| +376% | +$1.65M |
|
3113
CALL
O'Reilly Automotive
ORLY
$72.4B
| $452K | ﹤0.01% |
+6,000
| New | +$420K |
|
|
3114
PUT
O'Reilly Automotive
ORLY
$72.4B
| $452K | ﹤0.01% |
+6,000
| New | +$420K |
|
|
SBDS
3115
DELISTED
Solo Brands Inc
SBDS
| $450K | ﹤0.01% |
5,186
+3,355
| +183% | +$386K |
|
3116
Sarepta Therapeutics
SRPT
$1.66B
| $450K | ﹤0.01% |
+3,476
| New | +$426K |
|
3117
Genie Energy
GNE
$378M
| $450K | ﹤0.01% |
+29,837
| New | +$573K |
|
3118
SPX Corp
SPXC
$11B
| $450K | ﹤0.01% |
+3,652
| New | +$397K |
|
3119
Trinity Industries
TRN
$2.97B
| $449K | ﹤0.01% |
+16,115
| New | +$415K |
|
3120
Agilon Health
AGL
$1.64B
| $447K | ﹤0.01% |
2,931
-5,157
| -64% | -$858K |
|
3121
Enphase Energy
ENPH
$4.84B
| $445K | ﹤0.01% |
3,682
-22,606
| -86% | -$2.64M |
|
|
BOLD
3122
Boundless Bio
BOLD
$57.8M
| $445K | ﹤0.01% |
+31,250
| New | +$445K |
|
3123
Bally's
BALY
$672M
| $445K | ﹤0.01% |
31,897
-18,479
| -37% | -$215K |
|
3124
Virtus Investment Partners
VRTS
$1.11B
| $445K | ﹤0.01% |
1,793
-734
| -29% | -$174K |
|
3125
Smith & Wesson
SWBI
$655M
| $443K | ﹤0.01% |
25,525
-13,499
| -35% | -$195K |
|
Similar funds
Squarepoint's Q1 2024 Portfolio in Review
As of Q1 2024, Squarepoint held 4,799 positions worth $58.1B, up 10% from $52.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Squarepoint's Q1 2024 filing shows 857 new, 1,497 increased, 1,529 reduced and 854 closed positions. Its largest new stake was The Gap Inc: 3,316,943 shares worth $91.4M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, down from 9.3% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Squarepoint's largest Q1 2024 buy was The Gap Inc: 3,316,943 shares worth $91.4M.
- Squarepoint added most to iShares Core S&P 500 ETF in Q1 2024, an estimated $701M increase.
- Squarepoint's biggest Q1 2024 reduction was Invesco QQQ Trust, cutting an estimated $240M.
- Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q1 2024, selling an estimated $1.17B.
- Squarepoint's ten largest holdings make up 14% of its $58.1B portfolio in Q1 2024.
- Squarepoint opened 857 new positions and closed 854 in Q1 2024.
- Squarepoint's portfolio value rose 10% quarter-over-quarter to $58.1B.
Based on Squarepoint's 13F filing for Q1 2024, filed 15 May 2024.